Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species
- PMID: 16864896
- DOI: 10.1369/jhc.6A6930.2006
Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species
Abstract
A monoclonal antibody directed against the amino terminal of rat phosphodiesterase 10A (PDE10A) was used to localize PDE10A in multiple central nervous system (CNS) and peripheral tissues from mouse, rat, dog, cynomolgus macaque, and human. PDE10A immunoreactivity is strongly expressed in the CNS of these species with limited expression in peripheral tissues. Within the brain, strong immunoreactivity is present in both neuronal cell bodies and neuropil of the striatum, in striatonigral and striatopallidal white matter tracks, and in the substantia nigra and globus pallidus. Outside the brain, PDE10A immunoreactivity is less intense, and distribution is limited to few tissues such as the testis, epididymal sperm, and enteric ganglia. These data demonstrate that PDE10A is an evolutionarily conserved phosphodiesterase highly expressed in the brain but with restricted distribution in the periphery in multiple mammalian species.
Similar articles
-
Immunohistochemical localization of PDE10A in the rat brain.Brain Res. 2003 Sep 26;985(2):113-26. doi: 10.1016/s0006-8993(03)02754-9. Brain Res. 2003. PMID: 12967715
-
Phosphodiesterase-10A Inverse Changes in Striatopallidal and Striatoentopeduncular Pathways of a Transgenic Mouse Model of DYT1 Dystonia.J Neurosci. 2017 Feb 22;37(8):2112-2124. doi: 10.1523/JNEUROSCI.3207-15.2016. Epub 2017 Jan 23. J Neurosci. 2017. PMID: 28115486 Free PMC article.
-
Phosphodiesterase 10A inhibition is associated with locomotor and cognitive deficits and increased anxiety in mice.Eur Neuropsychopharmacol. 2008 May;18(5):339-63. doi: 10.1016/j.euroneuro.2007.08.002. Epub 2007 Oct 29. Eur Neuropsychopharmacol. 2008. PMID: 17913473
-
Phosphodiesterase 10A inhibitors: a novel approach to the treatment of the symptoms of schizophrenia.Curr Opin Investig Drugs. 2007 Jan;8(1):54-9. Curr Opin Investig Drugs. 2007. PMID: 17263185 Review.
-
PDE10A inhibitors: an assessment of the current CNS drug discovery landscape.Curr Opin Drug Discov Devel. 2009 Jul;12(4):458-67. Curr Opin Drug Discov Devel. 2009. PMID: 19562642 Review.
Cited by
-
Interplay between APC and ALDH1B1 in a newly developed mouse model of colorectal cancer.Chem Biol Interact. 2020 Nov 1;331:109274. doi: 10.1016/j.cbi.2020.109274. Epub 2020 Sep 29. Chem Biol Interact. 2020. PMID: 33007288 Free PMC article.
-
Phosphodiesterase 10A inhibitor MP-10 effects in primates: comparison with risperidone and mechanistic implications.Neuropharmacology. 2014 Feb;77:257-67. doi: 10.1016/j.neuropharm.2013.10.015. Neuropharmacology. 2014. PMID: 24490227 Free PMC article.
-
Suppression of Colon Tumorigenesis in Mutant Apc Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-Catenin.Cancer Prev Res (Phila). 2021 Nov;14(11):995-1008. doi: 10.1158/1940-6207.CAPR-21-0208. Epub 2021 Sep 28. Cancer Prev Res (Phila). 2021. PMID: 34584001 Free PMC article.
-
Preclinical Characterization of the Phosphodiesterase 10A PET Tracer [(11)C]MK-8193.Mol Imaging Biol. 2016 Aug;18(4):579-87. doi: 10.1007/s11307-015-0910-0. Mol Imaging Biol. 2016. PMID: 26596571
-
Pharmacological characterization of a novel potent, selective, and orally active phosphodiesterase 10A inhibitor, PDM-042 [(E)-4-(2-(2-(5,8-dimethyl-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)vinyl)-6-(pyrrolidin-1-yl)pyrimidin-4-yl)morpholine] in rats: potential for the treatment of schizophrenia.Pharmacol Res Perspect. 2016 Jun 10;4(4):e00241. doi: 10.1002/prp2.241. eCollection 2016 Aug. Pharmacol Res Perspect. 2016. PMID: 28116094 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources